Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology

药物滥用研究博士后培训:行为

基本信息

项目摘要

ABSTRACT This application responds to PA-20-142 and is the second competing continuation of a postdoctoral training program entitled “Training in drug abuse research: behavior and neurobiology” at the University of Texas Health Science Center at San Antonio (UTHSCSA). This Program has become an integral component of the recently launched Addiction Research, Treatment & Training Center of Excellence, the umbrella organization for a large variety of activities related to substance use disorder (SUD) on campus and extending into the San Antonio community. During the current period of support, all 6 training positions were filled with fellows selected from a pool of highly qualified applications. Since 2016, a total of 14 trainees have been or are currently supported by the Program, including 11 women (78%); 4 of the trainees (28%) are underrepresented minorities. Among 10 fellows that completed training, 8 are in academic positions. During the current period of support, trainees published 40 manuscripts (28 as first author), submitted 11 grant applications, and made 111 presentations at scientific meetings. Increasingly trainees are participating in community outreach activities, advocating for SUD research, education, and treatment. This Program sponsors numerous career development activities, many of which are attended by students and fellows, in addition to trainees in this Program. The well- funded research programs of the 18 Regular and 3 Junior faculty mentors span cell signaling to neurochemistry, preclinical behavioral pharmacology, and human clinical trials. The Program enjoys outstanding financial and other support from UTHSCSA (e.g., 10% salary for the Director), including an Office of Postdoctoral Affairs that offers many programs on career development, grant writing, and teaching, among others. Program Leadership includes a Director, Associate Director, Coordinator, and an Internal Advisory Committee. An External Advisory Committee evaluates the Program as part of an annual Advisory Committee Meeting in San Antonio; the details and operation of the Program as well as the training experience of fellows have improved as a result of recommendations by the Advisory Committees. The training environment at UTHSCSA is outstanding and includes excellent seminars, grand rounds, journal clubs (including the Addiction Journal Club hosted by this Program), formal training in rigor and reproducibility, formal training in the responsible conduct of research, and an annual international SUD meeting entitled Behavior, Biology & Chemistry: Translational Research in Addiction. This competing continuation requests 5 additional years of support for 6 positions in this highly successful, vibrant Program that is contributing to the NIDA mission of recruiting and training the next generation of SUD researchers.
摘要 本申请是对PA-20-142的响应,是博士后的第二个竞争性延续 德克萨斯大学题为“药物滥用研究培训:行为和神经生物学”的培训项目 圣安东尼奥健康科学中心(UTHSCSA)。本计划已成为 最近成立了成瘾研究、治疗和培训卓越中心,这是 与校园内的物质使用障碍(SUD)相关的各种活动,并延伸到SAN 安东尼奥社区。在本支助期间,所有6个培训职位都由选定的研究员填补。 从一个高度合格的应用程序池中。自2016年以来,共有14名学员已经或正在接受培训 在该方案的支持下,有11名妇女(78%);4名受训人员(28%)是代表性不足的少数群体。 在完成培训的10名研究员中,有8人在学术岗位上。在本支助期内, 学员发表了40篇手稿(28篇为第一作者),提交了11份赠款申请,并提出了111项 在科学会议上发表演讲。越来越多的受训人员参加社区外展活动, 倡导自闭症的研究、教育和治疗。该计划赞助了众多职业发展项目 活动,其中许多由学生和研究员参加,此外还有本计划的受训人员。这口井- 18名普通教师和3名初级教师导师资助的研究项目涵盖了细胞信号与神经化学, 临床前行为药理学和人体临床试验。该计划享有出色的财务和 UTHSCSA提供的其他支持(例如,主任的工资为10%),包括博士后事务办公室 提供许多关于职业发展、拨款撰写和教学等方面的课程。计划领导力 包括一名主任、副主任、协调员和一个内部咨询委员会。外部咨询 委员会在圣安东尼奥举行的年度咨询委员会会议上对该计划进行评估;细节 方案的运作以及研究员的培训经验因以下方面而有所改善 咨询委员会的建议。UTHSCSA的培训环境非常出色, 包括优秀的研讨会,盛大的回合,杂志俱乐部(包括由 方案)、严谨和可再现性的正式培训、负责任的研究行为的正式培训,以及 一年一度的国际SUD会议,题为行为,生物和化学:翻译研究 上瘾了。这一竞争性续聘要求为6个职位额外提供5年的支持 成功、充满活力的计划正在为NIDA招募和培训下一代的使命做出贡献 南德大学的研究人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES P FRANCE其他文献

CHARLES P FRANCE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES P FRANCE', 18)}}的其他基金

Methocinnamox (MCAM): A novel opioid receptor antagonist
Methocinnamox (MCAM):一种新型阿片受体拮抗剂
  • 批准号:
    10844948
  • 财政年份:
    2023
  • 资助金额:
    $ 46.33万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    10353379
  • 财政年份:
    2019
  • 资助金额:
    $ 46.33万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    9892987
  • 财政年份:
    2019
  • 资助金额:
    $ 46.33万
  • 项目类别:
Methocinnamox (MCAM): A novel õ-opioid receptor antagonist for opioid use disorders
Methocinnamox (MCAM):一种新型 α-阿片受体拮抗剂,用于治疗阿片类药物使用障碍
  • 批准号:
    10477526
  • 财政年份:
    2019
  • 资助金额:
    $ 46.33万
  • 项目类别:
Methocinnamox (MCAM): A novel õ-opioid receptor antagonist for opioid use disorders
Methocinnamox (MCAM):一种新型 α-阿片受体拮抗剂,用于治疗阿片类药物使用障碍
  • 批准号:
    10763458
  • 财政年份:
    2019
  • 资助金额:
    $ 46.33万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    10092999
  • 财政年份:
    2019
  • 资助金额:
    $ 46.33万
  • 项目类别:
A novel opioid receptor antagonist for treating abuse and overdose
一种用于治疗滥用和过量的新型阿片受体拮抗剂
  • 批准号:
    10561706
  • 财政年份:
    2019
  • 资助金额:
    $ 46.33万
  • 项目类别:
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5-HT2C 激动剂氯卡色林作为可卡因抗体潜在治疗方法的评估
  • 批准号:
    9008117
  • 财政年份:
    2013
  • 资助金额:
    $ 46.33万
  • 项目类别:
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5-HT2C 激动剂氯卡色林作为可卡因抗体潜在治疗方法的评估
  • 批准号:
    8714994
  • 财政年份:
    2013
  • 资助金额:
    $ 46.33万
  • 项目类别:
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab
5-HT2C 激动剂氯卡色林作为可卡因抗体潜在治疗方法的评估
  • 批准号:
    8652970
  • 财政年份:
    2013
  • 资助金额:
    $ 46.33万
  • 项目类别:

相似海外基金

The Neurobiology of Drug Abuse
药物滥用的神经生物学
  • 批准号:
    10555567
  • 财政年份:
    2017
  • 资助金额:
    $ 46.33万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8266367
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8678888
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
Training in drug abuse research: behavior and neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    9918882
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology
药物滥用研究博士后培训:行为
  • 批准号:
    10200482
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
药物滥用神经生物学培训计划
  • 批准号:
    8357409
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8484806
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
  • 批准号:
    8077836
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology
药物滥用研究博士后培训:行为
  • 批准号:
    10626044
  • 财政年份:
    2011
  • 资助金额:
    $ 46.33万
  • 项目类别:
TRAINING PROGRAM IN THE NEUROBIOLOGY OF DRUG ABUSE
药物滥用神经生物学培训计划
  • 批准号:
    8172339
  • 财政年份:
    2010
  • 资助金额:
    $ 46.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了